| (Values in U.S. Thousands) | Mar, 2026 | Mar, 2025 | Mar, 2024 | Mar, 2023 | Mar, 2022 |
| Sales | 50 | 70 | 130 | 370 | 350 |
| Sales Growth | -28.57% | -46.15% | -64.87% | +5.71% | +75.00% |
| Net Income | -3,300 | -3,080 | -2,310 | -1,880 | -2,080 |
| Net Income Growth | -7.14% | -33.33% | -22.87% | +9.62% | -34.19% |
Diagnos Inc (DGNOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
DIAGNOS Inc. provide commercialize technologies combining contextual imaging, text and traditional data mining services. It also developed Artificial Intelligence technologies, CARA and FLAIRE. FLAIRE is a powerful AI engine which provides the capability of analyzing large and complex data sets. DIAGNOS Inc. is based in Quebec, Canada.
Fiscal Year End Date: 03/31